A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3
- PMID: 21824976
- PMCID: PMC3188994
- DOI: 10.1093/hmg/ddr342
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3
Abstract
Genome-wide and candidate-gene association studies of bladder cancer have identified 10 susceptibility loci thus far. We conducted a meta-analysis of two previously published genome-wide scans (4501 cases and 6076 controls of European background) and followed up the most significant association signals [17 single nucleotide polymorphisms (SNPs) in 10 genomic regions] in 1382 cases and 2201 controls from four studies. A combined analysis adjusted for study center, age, sex, and smoking status identified a novel susceptibility locus that mapped to a region of 18q12.3, marked by rs7238033 (P = 8.7 × 10(-9); allelic odds ratio 1.20 with 95% CI: 1.13-1.28) and two highly correlated SNPs, rs10775480/rs10853535 (r(2)= 1.00; P = 8.9 × 10(-9); allelic odds ratio 1.16 with 95% CI: 1.10-1.22). The signal localizes to the solute carrier family 14 member 1 gene, SLC14A1, a urea transporter that regulates cellular osmotic pressure. In the kidney, SLC14A1 regulates urine volume and concentration whereas in erythrocytes it determines the Kidd blood groups. Our findings suggest that genetic variation in SLC14A1 could provide new etiological insights into bladder carcinogenesis.
Figures
References
-
- Silverman D., Devesa S.S., Moore L.E., Rothman N. Bladder Cancer. In: Schottenfeld D., Fraumeni J.F. Jr, editors. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006. pp. 1101–1127.
-
- Murta-Nascimento C., Silverman D.T., Kogevinas M., Garcia-Closas M., Rothman N., Tardon A., Garcia-Closas R., Serra C., Carrato A., Villanueva C., et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol. Biomarkers Prev. 2007;16:1595–1600. - PubMed
-
- Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst. 1993;85:1159–1164. - PubMed
-
- Garcia-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., Tardon A., Serra C., Carrato A., Garcia-Closas R., et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005;366:649–659. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HG004446/HG/NHGRI NIH HHS/United States
- U01 CA127615/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA 74880/CA/NCI NIH HHS/United States
- U01 CA 127615/CA/NCI NIH HHS/United States
- N01-RC-37004/RC/CCR NIH HHS/United States
- P50 CA 91846/CA/NCI NIH HHS/United States
- N01-CN-45165/CN/NCI NIH HHS/United States
- CA055075/CA/NCI NIH HHS/United States
- HG-06-033-NCI-01/PHS HHS/United States
- HHSN261200800001E/CA/NCI NIH HHS/United States
- U01HG004438/HG/NHGRI NIH HHS/United States
- N01-RC-45035/RC/CCR NIH HHS/United States
- P50 CA091846/CA/NCI NIH HHS/United States
- R01 CA074880/CA/NCI NIH HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- N02 CP011015/CP/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- U01HG00443/HG/NHGRI NIH HHS/United States
- R01HL091172-01/HL/NHLBI NIH HHS/United States
- CA087969/CA/NCI NIH HHS/United States
- HHSN268200782096C/HG/NHGRI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
